Enanta Pharmaceutica (ENTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2015 | 09-2014 | 09-2013 | 09-2012 | 09-2011 | |
| Sales | 160,880 | 47,741 | 32,053 | 41,706 | 41,882 |
| Gross Profit | 160,880 | 47,741 | 32,053 | 41,706 | 41,882 |
| Operating Expenses | 36,732 | 28,756 | 23,024 | 20,417 | 16,583 |
| Operating Income | 124,148 | 18,985 | 9,029 | 21,289 | 25,299 |
| Interest Expense | 8 | 18 | 31 | 0 | 3,161 |
| Other Income | 1,315 | 301 | 629 | 110 | 1,172 |
| Pre-tax Income | 125,455 | 19,268 | 9,627 | 21,399 | 23,310 |
| Income Tax | 46,463 | -15,170 | N/A | N/A | N/A |
| Net Income Continuous | 78,992 | 34,438 | 9,627 | 21,399 | 23,310 |
| Net Income | $78,992 | $34,438 | $9,627 | $21,399 | $23,310 |
| EPS Basic Total Ops | 4.23 | 1.88 | -0.67 | 1.26 | 1.40 |
| EPS Basic Continuous Ops | 4.23 | 1.88 | 0.98 | 19.65 | 20.83 |
| EPS Diluted Total Ops | 4.09 | 1.80 | -0.67 | 1.13 | 1.32 |
| EPS Diluted Continuous Ops | 4.09 | 1.80 | 0.98 | 8.65 | 12.55 |
| EBITDA(a) | $127,031 | $21,457 | $10,512 | $22,051 | $26,115 |